Navigation Links
Syntex Management Systems, Inc. to Discuss Enterprise Risk Management at the North American Petroleum Accounting Conference
Date:5/13/2009

HOUSTON, May 13 /PRNewswire/ -- Syntex Management Systems, Inc., world's leading provider of enterprise risk management solutions, is pleased to announce that Trent Derr, President and CEO for Syntex will present "Gaining a Corporate-Wide Picture Using Financial and Operational Data" at the North American Petroleum Accounting Conference on May 15, 2009 from 9:35 am-10:35 am. Syntex is proud to be a participant at the conference, now in its 32nd year, taking place May 14-15, 2009 at the Westin Galleria in Dallas, Texas.

NAPAC is the premiere oil and gas industry accounting conference will focus on professional development for Tax, Finance and Law, Financial Reporting and Internal Accounting and COPAS professionals. With multiple concurrent sessions from leading industry speakers and the annual exhibit showcasing a variety of products and services, attendees will have extensive educational and networking opportunities. Each year, NAPAC expands the range of topics to encompass the most relevant subject matter involving both the government and private sectors. Mr. Derr's presentation will focus on the benefits of a holistic approach to enterprise risk management, the positive affect it can have on the bottom line and the various steps in moving an organization from just a data reporting organization to one that can proactively manage risks.

Syntex's flagship software solution, IMPACT ERM(R) Suite is a comprehensive Enterprise Risk Management solution that helps companies significantly improve Operational, Corporate Assurance, Quality, Security, Health, Safety, and Environmental performance
'/>"/>

SOURCE Syntex Management Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Case Management Cost-Effective Way to Cut Heart Risks
2. S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time
3. Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies
4. Painless Hemorrhoid Treatment Adds Management Punch
5. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
6. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
7. Standard Management Announces OTCBB Listing
8. MDS Pharma Services Wins Award for Management of Global Malaria Trial
9. AWT Management Announce Aggressive Growth and Acquisition Strategy
10. Hospital Workers: Management Threatens Patient Care
11. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)..., , ATLANTA, Nov. 29 The fo... Intellivest Securities Research, Inc. ,, Intel...a registered investment advisor, has published a R...panies in the pharmaceutical, biotechnology and me...ping their clients manage, process and submit medi...
(Date:11/29/2009)..., , BLOOMINGTON, Minn., Nov. 29 /PRNewswire/ ...ce medical image management software, data migrati...ct offering called AcuoShare that allows image sha...p; affiliates. ,, The AcuoShare solution is bas...es Grid(TM) Software. The Acuo AcuoShare enables ...
(Date:11/29/2009)... "The YogaForce A-Line...quot; says Dr. Andrew Weil, M.D., author and physi...the field of integrative medicine. Go to www.yog...tness minded on the gift list. , ...9 -- Just in time for the holidays, the YogaForce ...
(Date:11/28/2009)...peat offenders were more likely to consider change...finds , , FRIDAY, Nov. 27 (HealthDay New... to consider why they should stop their dangerous ...changes, researchers have found. , The new stud...ing-while-impaired convictions, who were randomly ...
(Date:11/27/2009)..., , KELOWNA, BC, Nov. 27 /PRNewswire/ - Uploa...dy seeing prime time in wellness. A combination of...d data upload are solving a long term concern over...ible to accurately gauge and reward improved parti...chnologies is one of the first wellness suppliers ...
Breaking Medicine News(10 mins):Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:New USB technology adds accountability and convenience to wellness programs 2
...to death? Florida biochemist says coral-killing ...RLANDO, Fla., Feb. 11 If you care about coral ree...t Celia Ferreira, Ph.D.,advises., Scientists have...ublished in the January 2008 issue of,Environmenta...
... 11 Kay Renz Public Relations,has been retained b...ists,Peter G. Ballas MD, who has a thriving practi...s highly regarded nationally as one of the foremos...roducts. He is currently introducing Artefill (R),...
...t health care providers play a key role in the lik... cancer. The findings suggest that interventions t...ded to boost colorectal cancer screening rates, an...hed in the March 15, 2008 issue of CANCER, a peer-...
...ose weight" It might help to pour that diet soda d...e that the widespread use of no-calorie sweeteners... their intake and body weight. The findings appear...ersitys Ingestive Behavior Research Center reporte...
...searchers led by Fred Hutchinson Cancer Research C... why some recurrent ovarian tumors become resistan...hemotherapy drugs such as cisplatin and carboplati...with inherited mutations in the BRCA2 gene, they a...
...n may pose deadly burden , , SUNDAY, Feb. ..."widower" effect, and doctors have long been famil...en a husband or wife dies, there,s a greater likel...ems often start with the hospitalization of a sp...
Other Medicine News:Health News:Choose Biodegradable Sunscreen to Save Coral Reefs 2Health News:Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line 2Health News:Provider influence and patient barriers affect use of colorectal cancer screening 2Health News:Artificial sweeteners linked to weight gain 2Health News:Artificial sweeteners linked to weight gain 3Health News:Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy 2Health News:Spouse's Sickness Bodes Ill for Partner's Health 2Health News:Spouse's Sickness Bodes Ill for Partner's Health 3
(Date:11/29/2009)...CAGO, Nov. 29 FUJIFILM Medical Sys..., its revolutionary flat panel DR cassette, at the... Annual Meeting. Ideal for any clinical environme... provide clinicians with Fujifilm,s trademark imag...VO is a smart way for users to transition to DR wi...
(Date:11/29/2009)...CAGO, Nov. 29 Researchers using fu...y brain activation have found that men and women r...i, according to a study presented today at the ann...merica (RSNA). ,, "Men may direct more attentio... to process them in terms of implications for requ...
(Date:11/27/2009)...MINGTON, Minn, Nov. 27 ACUO TECHNO...ge management software, data migration tools and s...ates Patent and Trademark Office has approved a pa...t within a Computer Network." Acuo Technologies is...f intellectual property. In general, the granted p...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 1QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 2QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 3QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 4Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 1Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 2Rib X Pharmaceuticals to Present at the 49th ICAAC 13970 1Rib X Pharmaceuticals to Present at the 49th ICAAC 13970 2Rib X Pharmaceuticals to Present at the 49th ICAAC 13970 3Rib X Pharmaceuticals to Present at the 49th ICAAC 13970 4
... Eli Lilly and Company announced today that Phase...ZAR(R) (gemcitabine HCl for injection) to the curr...ificant increase in progression-free survival at t...l cancer. , , Cervical cancer is the world,s se...he second most common cause of cancer death in wom...
... Data from the Phase III ZODIAC study in advanced ...stigational drug vandetanib, were presented today ...) meeting in Orlando. Results show that the study ...ddition of vandetanib to docetaxel resulted in a s...n-free survival (PFS), the length of time a patien...
Other Medicine Technology:Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 2Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 3Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 4Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 5Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 6Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 2Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 3Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 4Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 5
...HME product line has the right product for any pat...tubated patients to patients with tracheotomies. T...th anesthesia and critical care applications., ,T...rotection for patients and staff members. This ent...
...HME product line has the right product for any pat...tubated patients to patients with tracheotomies. T...th anesthesia and critical care applications., ,T...rotection for patients and staff members. This ent...
High Performance HME with Port
Breathe-Easy™ with Suction Valve for Tracheotomies
Medicine Products: